Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Other Announcement

Molbio Diagnostics Other Announcement

Molbio Diagnostics filed CRISIL's monitoring agency report on IPO proceeds utilisation for the quarter ended 30 September 2026. The report states no deviation from the issue objects.

Source

NSE filing, NSE: MOLBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Molbio Diagnostics Ltd: key numbers

Share price
₹1,347.00
Market cap
₹15,523 Cr
Revenue (annual)
₹1,446 Cr
Net profit (annual)
₹166.6 Cr
P/E (TTM)
100.5×Sector 53.4×
Promoter holding
41.29%
FII holding
1.59%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Molbio Diagnostics Ltd

All →

Other other announcement announcements

All →